Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Guangzhou Baiyunshan Pharmaceutical Holdings Company ( (HK:0874) ) just unveiled an update.
Guangzhou Baiyunshan Pharmaceutical Holdings Company has announced the convening of its third extraordinary general meeting (EGM) in 2025, scheduled for December 30th. The meeting will address key resolutions including the asset-backed securitization of accounts receivable and the settlement of projects invested by proceeds, along with the permanent replenishment of working capital. This meeting is significant for stakeholders as it involves strategic financial decisions that could impact the company’s liquidity and financial management.
The most recent analyst rating on (HK:0874) stock is a Buy with a HK$21.00 price target. To see the full list of analyst forecasts on Guangzhou Baiyunshan Pharmaceutical Holdings Company stock, see the HK:0874 Stock Forecast page.
More about Guangzhou Baiyunshan Pharmaceutical Holdings Company
Guangzhou Baiyunshan Pharmaceutical Holdings Company is a joint stock company with limited liability established in the People’s Republic of China. It operates in the pharmaceutical industry, focusing on the development, production, and distribution of pharmaceutical products.
Average Trading Volume: 1,242,778
Technical Sentiment Signal: Buy
Current Market Cap: HK$44.18B
Find detailed analytics on 0874 stock on TipRanks’ Stock Analysis page.